计算溶液所需的质量、体积或浓度。
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
A111275-20mg |
20mg |
现货 ![]() |
| |
A111275-100mg |
100mg |
现货 ![]() |
| |
A111275-500mg |
500mg |
现货 ![]() |
| |
A111275-2.5g |
2.5g |
现货 ![]() |
|
别名 | 黄芪甲甙 |
---|---|
英文别名 | Astragaloside A | AKOS025311424 | AKOS027470287 | CCG-270470 | HMS3885E12 | Astrasieversianin XIV | s3901 | (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethy |
规格或纯度 | 分析标准品, ≥98% |
英文名称 | Astragaloside IV |
生化机理 | 消炎。 |
应用 | 黄芪化学成分的研究 |
运输条件 | 常规运输 |
产品介绍 |
黄芪化学成分的研究 |
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504767538 |
---|---|
分子类型 | 小分子 |
IUPAC Name | (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
INCHI | InChI=1S/C41H68O14/c1-35(2)24(54-33-29(48)26(45)20(44)17-51-33)9-11-41-18-40(41)13-12-37(5)31(39(7)10-8-25(55-39)36(3,4)50)19(43)15-38(37,6)23(40)14-21(32(35)41)52-34-30(49)28(47)27(46)22(16-42)53-34/h19-34,42-50H,8-18H2,1-7H3/t19-,20+,21-,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34+,37+,38-,39+,40-,41+/m0/s1 |
InChi Key | QMNWISYXSJWHRY-YLNUDOOFSA-N |
Canonical SMILES | CC1(C(CCC23C1C(CC4C2(C3)CCC5(C4(CC(C5C6(CCC(O6)C(C)(C)O)C)O)C)C)OC7C(C(C(C(O7)CO)O)O)O)OC8C(C(C(CO8)O)O)O)C |
Isomeric SMILES | C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@]6(CC[C@H](O6)C(C)(C)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)(C)C)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O |
WGK Germany | 3 |
PubChem CID | 13943297 |
分子量 | 784.97 |
密度 | 1.39 |
---|---|
熔点 | 295-296°C |
分子量 | 785.000 g/mol |
XLogP3 | 1.300 |
氢键供体数Hydrogen Bond Donor Count | 9 |
氢键受体数Hydrogen Bond Acceptor Count | 14 |
可旋转键计数Rotatable Bond Count | 7 |
精确质量Exact Mass | 784.461 Da |
单同位素质量Monoisotopic Mass | 784.461 Da |
拓扑极表面积Topological Polar Surface Area | 228.000 Ų |
重原子数Heavy Atom Count | 55 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 1460.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 21 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
WGK Germany | 3 |
---|---|
个人防护装备 | Eyeshields,Gloves,type N95 (US),type P1 (EN143) respirator filter |
Purity(HPLC) | 98-100(%) |
---|---|
Melting point | 295-296(℃) |
Appearance(A111275) | Colorless or White Powder |
Mass spectrum | Conforms to standard |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 24-11-20 | A111275 |
![]() |
分析证书 | 24-11-20 | A111275 |
![]() |
分析证书 | 24-11-05 | A111275 |
![]() |
分析证书 | 24-02-05 | A111275 |
![]() |
分析证书 | 24-02-05 | A111275 |
![]() |
分析证书 | 24-02-05 | A111275 |
![]() |
分析证书 | 24-02-05 | A111275 |
![]() |
分析证书 | 22-09-20 | A111275 |
![]() |
分析证书 | 22-09-20 | A111275 |
![]() |
分析证书 | 22-09-20 | A111275 |
1. Chan-juan Chai, Yao Sun, Rui-fang Chi, Hui-yu Yang, Bin Yang, Bao Li. (2024) Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-κB signaling pathway. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 693 (149367). [PMID:38091841] [10.1016/j.bbrc.2023.149367] |
2. Xin Zhao, Jinlong Luo, Ying Huang, Lei Mu, Jueying Chen, Zhen Liang, Zhanhai Yin, Dake Chu, Yong Han, Baolin Guo. (2023) Injectable Antiswelling and High-Strength Bioactive Hydrogels with a Wet Adhesion and Rapid Gelling Process to Promote Sutureless Wound Closure and Scar-free Repair of Infectious Wounds. ACS Nano, 17 (21): (22015–22034). [PMID:37862553] [10.1021/acsnano.3c08625] |
3. Qing Xu, Dekun Li, Meixu Wan, Yanxin Zhang, Zhi Li, Aichun Ju. (2023) An Online CMC–LC/MS Method for Screening Angiogenesis Promoting Components in Yiqi Fumai Lyophilization Injection (YQFM). Natural Product Communications, [10.1177/1934578X231182209] |
4. Tianshu Chu, Qingye Li, Chun Dai, Xiang Li, Xiang Kong, Yangming Fan, Hongyan Yin, Jianjun Ge. (2023) A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts. Bioactive Materials, 22 (466). [PMID:36330163] [10.1016/j.bioactmat.2022.10.013] |
5. Xiaoyu Zhu, Fangze Tao, Li Zhang, Yajie Yu, Yanchao Xu, Gang Yang, Zhifeng Wei, Yidong Cheng, Xuelai Yin, Xinyuan Zhang, Wu Wei, Anxi Wang. (2022) Astragaloside IV Protects Detrusor from Partial Bladder Outlet Obstruction-Induced Oxidative Stress by Activating Mitophagy through AMPK-ULK1 Pathway. Oxidative Medicine and Cellular Longevity, 2022 (5757367). [PMID:35873803] [10.1155/2022/5757367] |
6. Xiaowei Wang, Yufen Li, Ji Li, Yaxuan Gu, Lihong Sang, Dongkai Wang. (2021) NIR stimulus-responsive AstragalosideIV-Indocyanin green liposomes for chemo-photothermal therapy. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 64 (102257). [10.1016/j.jddst.2020.102257] |
7. Dongyu Xie, Ping Zhou, Lin Liu, Wenjing Jiang, Haina Xie, Liang Zhang, Donghao Xie. (2019) Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload. Biomed Research International, 2019 (3103946). [PMID:31428632] [10.1155/2019/3103946] |
8. Jiamao Lin, Lijun Fang, Hui Li, Zhenxiang Li, Linmao Lyu, Haiyong Wang, Jun Xiao. (2019) Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress. EUROPEAN JOURNAL OF PHARMACOLOGY, 859 (172490). [PMID:31229536] [10.1016/j.ejphar.2019.172490] |
9. Lu Jianrao, Yi Yang, Pan Ronghua, Zhang Chuanfu, Han Haiyan, Chen Jie, Liu Wenrui. (2018) Berberine protects HK-2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression. Journal of Natural Medicines, 72 (2): (390-398). [PMID:29260413] [10.1007/s11418-017-1152-z] |
1. Chan-juan Chai, Yao Sun, Rui-fang Chi, Hui-yu Yang, Bin Yang, Bao Li. (2024) Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-κB signaling pathway. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 693 (149367). [PMID:38091841] [10.1016/j.bbrc.2023.149367] |
2. Xin Zhao, Jinlong Luo, Ying Huang, Lei Mu, Jueying Chen, Zhen Liang, Zhanhai Yin, Dake Chu, Yong Han, Baolin Guo. (2023) Injectable Antiswelling and High-Strength Bioactive Hydrogels with a Wet Adhesion and Rapid Gelling Process to Promote Sutureless Wound Closure and Scar-free Repair of Infectious Wounds. ACS Nano, 17 (21): (22015–22034). [PMID:37862553] [10.1021/acsnano.3c08625] |
3. Qing Xu, Dekun Li, Meixu Wan, Yanxin Zhang, Zhi Li, Aichun Ju. (2023) An Online CMC–LC/MS Method for Screening Angiogenesis Promoting Components in Yiqi Fumai Lyophilization Injection (YQFM). Natural Product Communications, [10.1177/1934578X231182209] |
4. Tianshu Chu, Qingye Li, Chun Dai, Xiang Li, Xiang Kong, Yangming Fan, Hongyan Yin, Jianjun Ge. (2023) A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts. Bioactive Materials, 22 (466). [PMID:36330163] [10.1016/j.bioactmat.2022.10.013] |
5. Xiaoyu Zhu, Fangze Tao, Li Zhang, Yajie Yu, Yanchao Xu, Gang Yang, Zhifeng Wei, Yidong Cheng, Xuelai Yin, Xinyuan Zhang, Wu Wei, Anxi Wang. (2022) Astragaloside IV Protects Detrusor from Partial Bladder Outlet Obstruction-Induced Oxidative Stress by Activating Mitophagy through AMPK-ULK1 Pathway. Oxidative Medicine and Cellular Longevity, 2022 (5757367). [PMID:35873803] [10.1155/2022/5757367] |
6. Xiaowei Wang, Yufen Li, Ji Li, Yaxuan Gu, Lihong Sang, Dongkai Wang. (2021) NIR stimulus-responsive AstragalosideIV-Indocyanin green liposomes for chemo-photothermal therapy. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 64 (102257). [10.1016/j.jddst.2020.102257] |
7. Dongyu Xie, Ping Zhou, Lin Liu, Wenjing Jiang, Haina Xie, Liang Zhang, Donghao Xie. (2019) Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload. Biomed Research International, 2019 (3103946). [PMID:31428632] [10.1155/2019/3103946] |
8. Jiamao Lin, Lijun Fang, Hui Li, Zhenxiang Li, Linmao Lyu, Haiyong Wang, Jun Xiao. (2019) Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress. EUROPEAN JOURNAL OF PHARMACOLOGY, 859 (172490). [PMID:31229536] [10.1016/j.ejphar.2019.172490] |
9. Lu Jianrao, Yi Yang, Pan Ronghua, Zhang Chuanfu, Han Haiyan, Chen Jie, Liu Wenrui. (2018) Berberine protects HK-2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression. Journal of Natural Medicines, 72 (2): (390-398). [PMID:29260413] [10.1007/s11418-017-1152-z] |